Laboratory Corp of America(R) Holdings, Burlington, NC reports that Yale University released the results of its Phase II study on a blood test to detect early-stage ovarian cancer. Using six biomarkers, the test discriminates between disease-free women and ovarian cancer patients (stage I-IV) with high specificity (99.4%) and sensitivity (95.3%).
Read MoreThe standard test for measuring blood sugar control in people with diabetes is not accurate in those on kidney hemodialysis, according to new research at Wake Forest University Baptist Medical Center, Winston-Salem, NC.
Read MoreGenzyme Genetics, Cambridge, Mass, has signed a sublicense agreement with DxS Ltd, Manchester, UK in which it will grant DxS worldwide rights with the exception of North America and Hong Kong for diagnostic testing of epidermal growth factor receptor mutations in non-small cell lung cancer.
Read MoreMIT researchers have explained why two mutations in the H1N1 avian flu virus allowed the disease to spread during the 1918 pandemic that killed at least 50 million people. The work could help scientists detect and contain a future bird flu outbreak among humans.
Read MoreThe new Kimtech Science benchtop protector from Kimberly-Clark Professional, Roswell, Ga, features a polyethylene backing that creates a fluid barrier while providing slip resistance.
Read More